3B Pharmaceuticals GmbH

Discovery Technologies

Discovery Technologies

3B Pharmaceuticals have built a drug discovery platform extending from hit identification to early clinical development. Several drug candidates developed through our platform already have been successfully administered to humans. The entire platform as well as certain broadly applicable technologies are available to our partners:

• Peptide drug discovery programs
• Plasma protein binding studies for any sort of compound with our proprietary EScalate® Assay
• Custom peptide affinity chromatography (PurAffin®) for bioprocess applications